Evidence map›Paper›PMID 9399955›Full record

ArticleThe Journal of clinical investigation1997

Blockade of CD49d (alpha4 integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma.

W R Henderson, E Y Chi, R K Albert, S J Chu, W J Lamm, Y Rochon, M Jonas, P E Christie, J M Harlan

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 171 citations in OpenAlex.

  1. Article
  2. Article
  3. Asthma-protective agents in dust from traditional farm environments.The Journal of allergy and clinical immunology · 2023
    Article
  4. Article
  5. Article
  6. Lung-Infiltrating Foxp3Journal of immunology (Baltimore, Md. : 1950) · 2017
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Novel targeted therapies for eosinophilic disorders.The Journal of allergy and clinical immunology · 2012
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

W R HendersonDepartment of Medicine, University of Washington, Seattle, Washington 98195, USA.
E Y Chi
R K Albert
S J Chu
W J Lamm
Y Rochon
M Jonas
P E Christie
J M Harlan
University of Washington · US

Funding

TOXIC OXYGEN PRODUCTS AND PULMONARY EDEMAP50HL030542 · NHLBI · UNIVERSITY OF WASHINGTON · PI HUDSON, LEONARD D · 1985 to 2003
$6.1M
MAST CELL-EOSINOPHIL INTERACTION IN ALLERGIC INJURYR01AI017758 · NIAID · UNIVERSITY OF WASHINGTON · PI HENDERSON, WILLIAM REED · 1985 to 1995
–
ROLE OF 5-LIPOXYGENASE PRODUCTS IN AIRWAY INFLAMMATIONU01AI034578 · NIAID · UNIVERSITY OF WASHINGTON · PI HENDERSON, WILLIAM REED · 1993 to 1996
–
NHLBI NIH HHS HL-30542NIAID NIH HHS AI-17758NIAID NIH HHS AI-34578
6 · The paper itself

Abstract

Immunized mice after inhalation of specific antigen have the following characteristic features of human asthma: airway eosinophilia, mucus and Th2 cytokine release, and hyperresponsiveness to methacholine. A model of late-phase allergic pulmonary inflammation in ovalbumin-sensitized mice was used to address the role of the alpha4 integrin (CD49d) in mediating the airway inflammation and hyperresponsiveness. Local, intrapulmonary blockade of CD49d by intranasal administration of CD49d mAb inhibited all signs of lung inflammation, IL-4 and IL-5 release, and hyperresponsiveness to methacholine. In contrast, CD49d blockade on circulating leukocytes by intraperitoneal CD49d mAb treatment only prevented the airway eosinophilia. In this asthma model, a CD49d-positive intrapulmonary leukocyte distinct from the eosinophil is the key effector cell of allergen-induced pulmonary inflammation and hyperresponsiveness.

Indexed as

AllergensAnimalsAntibodies, MonoclonalAntigens, CDAsthmaBronchoconstrictor AgentsCell MovementDisease Models, AnimalEosinophilsFemaleHumansIntegrin alpha4LeukocytesLungMethacholine ChlorideMiceAllergensAntibodies, MonoclonalAntigens, CDBronchoconstrictor AgentsIntegrin alpha4Methacholine ChlorideOvalbumin

Identifiers

PMID9399955
PMCPMC508521
OpenAlexW1979670373

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.